Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBritish American Tobacco Regulatory News (BATS)

Share Price Information for British American Tobacco (BATS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 2,355.00
Bid: 2,360.00
Ask: 2,361.00
Change: -16.00 (-0.67%)
Spread: 1.00 (0.042%)
Open: 2,371.00
High: 2,386.00
Low: 2,355.00
Prev. Close: 2,371.00
BATS Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

US Bond Issue by B.A.T Capital Corporation

4 Sep 2019 07:00

RNS Number : 1196L
British American Tobacco PLC
04 September 2019
 

4 September 2019

 

British American Tobacco Announces Pricing of $3,500,000,000 Notes Offering

 

British American Tobacco p.l.c. ("BAT") today announces that B.A.T Capital Corporation (the "Issuer"), a wholly owned subsidiary of BAT, has priced an offering of $3,500,000,000 aggregate principal amount of guaranteed debt securities, consisting of (1) $1,000,000,000 2.789% Notes due 2024; (2) $1,000,000,000 3.215% Notes due 2026; (3) $500,000,000 3.462% Notes due 2029; and (4) $1,000,000,000 4.758% Notes due 2049 (collectively, the "Notes"). The issuance is expected to close on 6 September 2019, subject to customary closing conditions.

The Notes will be fully and unconditionally guaranteed on a senior and unsecured and joint and several basis by BAT, B.A.T. Netherlands Finance B.V., B.A.T. International Finance p.l.c. and Reynolds American Inc. (together, the "Guarantors").

BAT intends to use the net proceeds of the offering of the Notes to refinance upcoming maturities, to potentially redeem prior to maturity some of the BAT Group's bonds and for general corporate purposes.

BofA Securities, Inc., Barclays Capital Inc., Citigroup Global Markets Inc., Deutsche Bank Securities Inc. and HSBC Securities (USA) Inc. are acting as joint book-running managers for the proposed offering.

The offering of the Notes will be made under BAT's existing effective shelf registration statement on file with the Securities and Exchange Commission (the "SEC"), which is available online at www.sec.gov. A preliminary prospectus supplement and accompanying prospectus describing the terms of the offering and other information relating to the Issuer and the Guarantors have been filed with the SEC. The shelf registration statement, the preliminary prospectus supplement and the accompanying prospectus may be obtained, free of charge, by contacting BofA Securities, Inc. at +1 800 294 1322, Barclays Capital Inc. at +1 888 603 5847, Citigroup Global Markets Inc. at +1 800 831 9146, Deutsche Bank Securities Inc. at +1 866 811 8049, or HSBC Securities (USA) Inc. at +1 866 811 8049.

The preliminary prospectus supplement is also available at:

https://www.sec.gov/Archives/edgar/data/1275283/000119312519236042/d770456d424b5.htm 

The shelf registration statement is also available at:

https://www.sec.gov/Archives/edgar/data/1275283/000119312519195742/d776937df3asr.htm

 

This communication shall not constitute an offer to sell nor a solicitation of an offer to buy the Notes. This offering is being made only pursuant to the Form F-3 registration statement, the prospectus supplement and the accompanying prospectus and only to such persons and in such jurisdictions as is permitted under applicable law.

Enquiries:

 

Investor Relations

Mike Nightingale / Rachael Brierley / John Harney

+44 (0)20 7845 1180 / 1519 / 1263

 

Press Office

+44 (0)20 7845 2888 (24 hours) | @BATPress 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
MSCUOSARKWAKRUR
Date   Source Headline
12th May 20234:45 pmRNSDirector/PDMR Shareholding
12th May 202312:10 pmRNSHolding(s) in Company
11th May 20233:25 pmRNSDirector/PDMR Shareholding
9th May 20234:00 pmRNSDirector/PDMR Shareholding
5th May 20232:55 pmRNSDirector/PDMR Shareholding
5th May 20232:50 pmRNSDirector/PDMR Shareholding
5th May 20232:45 pmRNSDirector/PDMR Shareholding
4th May 20233:35 pmRNSDirector/PDMR Shareholding
4th May 20231:10 pmRNSDirector/PDMR Shareholding
2nd May 20239:50 amRNSTotal Voting Rights
25th Apr 20234:05 pmRNSAgreement with the US Department of Justice
24th Apr 20237:15 amRNSDirector Declaration
19th Apr 20235:45 pmRNSResult of AGM
19th Apr 202311:45 amRNSAGM Statement
6th Apr 20231:20 pmRNSDirector/PDMR Shareholding
5th Apr 20234:15 pmRNSDirector/PDMR Shareholding
3rd Apr 20234:39 pmRNSDirector/PDMR Shareholding
3rd Apr 202311:05 amRNSTotal Voting Rights
31st Mar 20234:55 pmRNSDirector/PDMR Shareholding
31st Mar 20234:50 pmRNSDirector/PDMR Shareholding
31st Mar 20234:45 pmRNSDirector/PDMR Shareholding
23rd Mar 20232:50 pmRNSDirector/PDMR Shareholding
23rd Mar 20232:45 pmRNSDirector/PDMR Shareholding
23rd Mar 20232:40 pmRNSDirector/PDMR Shareholding
14th Mar 20234:47 pmRNSPublication of a Prospectus
14th Mar 20238:00 amRNSNotice of AGM
13th Mar 20233:10 pmRNSDirector/PDMR Shareholding
13th Mar 20237:00 amRNSBranch Register: Dividend Finalisation Information
9th Mar 202310:35 amRNSDirector/PDMR Shareholding
8th Mar 202311:10 amRNSDirector/PDMR Shareholding
3rd Mar 20234:40 pmRNSDirector/PDMR Shareholding
3rd Mar 202310:15 amRNSDirector Declaration
2nd Mar 20234:55 pmRNSAnnual Financial Report
1st Mar 202310:00 amRNSTotal Voting Rights
23rd Feb 202311:15 amRNSDirector/PDMR Shareholding
15th Feb 20236:05 pmRNSDirector Declaration
15th Feb 202310:30 amRNSDirector/PDMR Shareholding
14th Feb 20236:15 pmRNSPublication of Final Terms
13th Feb 202310:00 amRNSDirector/PDMR Shareholding
9th Feb 20234:10 pmRNSPublication of Supplementary Prospectus
9th Feb 20237:03 amRNSFinal Results
6th Feb 202312:35 pmRNSDirector/PDMR Shareholding
6th Feb 202312:30 pmRNSDirector/PDMR Shareholding
6th Feb 202312:25 pmRNSDirector/PDMR Shareholding
6th Feb 202312:20 pmRNSDirector/PDMR Shareholding
6th Feb 202312:15 pmRNSDirector/PDMR Shareholding
3rd Feb 202310:30 amRNSDirector/PDMR Shareholding
1st Feb 202312:00 pmRNSTotal Voting Rights
31st Jan 20237:00 amRNSManagement Board Changes & New Regional Structure
5th Jan 202312:30 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.